Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Industry Developments: As of May 2024, around 38 million Americans live with diabetes, with 90-95% having type 2 diabetes-a condition increasingly affecting younger populations
The landmark SURMOUNT-5 trial , published in the New England Journal of Medicine, was the first head-to-head trial comparing the two medications in adults with obesity but without type 2 diabetes
Whats next for employers and GLP-1s
Zhang Y, Zhou H, Wu W, Shi C, Hu S, Yin T, et al
Semaglutide faces competition from other GLP-1 receptor agonists, as well as DPP-4 inhibitors, SGLT2 inhibitors, and insulin therapies
Early action is strongly recommended to ensure prompt filing of an Ozempic lawsuit
